EP1175439A4 - 49 humane sekretierte proteine - Google Patents

49 humane sekretierte proteine

Info

Publication number
EP1175439A4
EP1175439A4 EP00921732A EP00921732A EP1175439A4 EP 1175439 A4 EP1175439 A4 EP 1175439A4 EP 00921732 A EP00921732 A EP 00921732A EP 00921732 A EP00921732 A EP 00921732A EP 1175439 A4 EP1175439 A4 EP 1175439A4
Authority
EP
European Patent Office
Prior art keywords
secreted proteins
human secreted
human
proteins
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00921732A
Other languages
English (en)
French (fr)
Other versions
EP1175439A1 (de
Inventor
Steven M Ruben
George Komatsoulis
Craig A Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP1175439A1 publication Critical patent/EP1175439A1/de
Publication of EP1175439A4 publication Critical patent/EP1175439A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP00921732A 1999-04-09 2000-04-06 49 humane sekretierte proteine Withdrawn EP1175439A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12869499P 1999-04-09 1999-04-09
US128694P 1999-04-09
US17693100P 2000-01-20 2000-01-20
US176931P 2000-01-20
PCT/US2000/009071 WO2000061629A1 (en) 1999-04-09 2000-04-06 49 human secreted proteins

Publications (2)

Publication Number Publication Date
EP1175439A1 EP1175439A1 (de) 2002-01-30
EP1175439A4 true EP1175439A4 (de) 2002-10-09

Family

ID=26826853

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00921732A Withdrawn EP1175439A4 (de) 1999-04-09 2000-04-06 49 humane sekretierte proteine

Country Status (5)

Country Link
EP (1) EP1175439A4 (de)
JP (1) JP2003501011A (de)
AU (1) AU4200900A (de)
CA (1) CA2370489A1 (de)
WO (1) WO2000061629A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030232056A1 (en) 1999-09-10 2003-12-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US6710170B2 (en) 1999-09-10 2004-03-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
WO2001081634A2 (en) * 2000-04-26 2001-11-01 Millennium Pharmaceuticals, Inc. Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941
AU6531101A (en) * 2000-06-02 2001-12-17 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP2008289482A (ja) * 2000-11-14 2008-12-04 Corixa Corp 卵巣癌の治療および診断のための組成物および方法
US20030120040A1 (en) 2001-06-29 2003-06-26 Genentech, Inc. Secreted and Transmembrane polypeptides and nucleic acids encoding the same
WO2003020307A1 (en) * 2001-08-31 2003-03-13 The General Hospital Corporation Bone morphogenic protein 2-induced genes and polypeptides, and their use in diagnostic and therapeutic methods
US20050123925A1 (en) 2002-11-15 2005-06-09 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
RU2380411C2 (ru) 2004-07-20 2010-01-27 Дженентек, Инк. Способ ингибирования пролиферации гепатоцитов, способ ингибирования клеточной адгезии гепатоцитов и способ ингибирования биологической активности angptl4 в гепатоцитах или предшественниках гепатоцитов
US8604185B2 (en) 2004-07-20 2013-12-10 Genentech, Inc. Inhibitors of angiopoietin-like 4 protein, combinations, and their use
JP4947717B2 (ja) 2004-07-20 2012-06-06 ジェネンテック， インコーポレイテッド アンジオポエチン様４タンパク質のインヒビター、組み合わせ、およびそれらの使用
AR059900A1 (es) 2006-03-17 2008-05-07 Genentech Inc Anticuerpos anti-tat226 e inmunoconjugados
BRPI0807635A2 (pt) * 2007-02-22 2014-06-03 Genentech Inc Métodos para detecção de doença inflamatória intestinal
SG172889A1 (en) * 2009-01-21 2011-08-29 Massachusetts Inst Technology Compositions and methods for assessing cytotoxicity of single cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654139A (en) * 1994-09-21 1997-08-05 The United States Of America As Represented By The Department Of Health And Human Services Allelic variation of the serotonin 5HT2c receptor

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] "Human DNA sequence from clone RP1-68O2 on chromosome 22", XP002198453, Database accession no. Z82215 *
See also references of WO0061629A1 *

Also Published As

Publication number Publication date
CA2370489A1 (en) 2000-10-19
AU4200900A (en) 2000-11-14
WO2000061629A1 (en) 2000-10-19
JP2003501011A (ja) 2003-01-14
EP1175439A1 (de) 2002-01-30

Similar Documents

Publication Publication Date Title
EP1218408A4 (de) 32 menschliche, sekretierte proteine
EP1212343A4 (de) 52 menschliche sekretierte proteine
EP1224285A4 (de) 27 menschliche sekretierte proteine
EP1212342A4 (de) 18 human-sekretierte proteine
EP1226231A4 (de) 19 humane sekretierte proteine
EP1175438A4 (de) 62 humane sekretierte proteine
EP1192278A4 (de) 48 menschliche sekretierte proteine
EP1192176A4 (de) 49 menschliche sekretierte proteine
EP1175439A4 (de) 49 humane sekretierte proteine
EP1165827A4 (de) 45 humane sekretierte proteine
EP1159284A4 (de) 33 human sekrteierte proteine
EP1189917A4 (de) 48 menschliche sekretierte proteine
EP1185543A4 (de) 50 human-sekretierte proteine
EP1224201A4 (de) 32 vom menschen abgesonderte proteine
EP1173477A4 (de) 49 humane sekretierte Proteine
EP1206573A4 (de) 26 humane sekretionsproteine
EP1203005A4 (de) 25 humane sekretierte proteine
EP1171460A4 (de) 48 menschliche sekretierte proteine
EP1144614A4 (de) Menschliche, ausgeschiedene proteine
EP1169332A4 (de) 49 human sekrtierte proteine
EP1165602A4 (de) 49 menschliche, sekretierte proteine
EP1165828A4 (de) 50 menschliche sekretierte proteine
EP1237901A4 (de) 28 menschliche sekretierte proteine
EP1228082A4 (de) 29 humansekretierte proteine
EP1185285A4 (de) 49 humane sekretierte proteine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011108

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20020827

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20040319

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040730